Ignite Creation Date:
2024-05-06 @ 6:16 PM
Last Modification Date:
2024-10-26 @ 2:44 PM
Study NCT ID:
NCT05602428
Status:
COMPLETED
Last Update Posted:
2022-11-02
First Post:
2022-09-20
Brief Title:
Analysis of Clinical Effect of Subanesthetic Dose of Esketamine Combined With Hip Capsule Peripheral Nerve Block in Elderly Patients Undergoing Total Hip Arthroplasty
Sponsor:
Changzhou Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine
Organization:
Changzhou Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine
Study Overview
Official Title:
Traditional Chinese Medicine Hospital of Changzhou Affiliated to Nanjing University of Traditional Chinese Medicine
Status:
COMPLETED
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To observe the clinical effect of esketamine combined with hip capsule peripheral nerve block in elderly patients undergoing total hip arthroplasty A total of 120 elderly patients who underwent total hip arthroplasty in our hospital from January 2020 to May 2021 were randomly divided into three groups 40 cases in each group The observation group A was treated with esketamine subanesthetic dose combined with hip capsule peripheral nerve block the control group B was treated with esketamine subanesthetic dose combined with lumbar plexus block and the control group C was treated with esketamine subanesthetic dose for general anesthesia The onset time of anesthesia duration of block postoperative recovery time postoperative extubation time MAP and HR indexes before anesthesia T0 during skin incision T1 30 minutes after the start of surgery T2 and at the end of surgery T3 were recorded in the three groups and the VAS score and Ramsay score at 05 h 2 h 6 h 12 h and 24 h after surgery as well as the incidence of postoperative adverse reactions were recorded in the three groups
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None